Committee

This Symposium has Concluded

Co-Chairs

A.L. Burlingame
Department of Pharmaceutical Chemistry
University of California, San Francisco, CA, USA

John T. Stults
Genentech, Inc.
South San Francisco, CA, USA

Ruedi H. Aebersold
Swiss Federal Institute of Technology, Zürich, Switzerland
and Institute for Systems Biology, Seattle, WA, USA

Simon J. Gaskell
The University of Manchester
Michael Barber Center for MS
Manchester, United Kingdom

Conference Coordinator

Nancy Wang
Mass Spectrometry Facility
Department of Pharmaceutical Chemistry
University of California, San Francisco, CA, USA 94143-0446
+1 (415) 476-2582

Organizing Committee

Thomas A. Baillie Merck Research Laboratories, West Point, PA, USA
John J.M. Bergeron McGill University, Montreal, Canada
Ralph A. Bradshaw University of California, San Francisco, CA, USA
Steven A. Carr Broad Institute, Cambridge, MA, USA
Catherine E. Costello Boston University, Boston, MA, USA
Raymond J. Deshaies California Institute of Technology, Pasadena, CA, USA
Emilio Gelpi Institute for Biomedical Investigation (IIBB-CSIC), Barcelona, Spain
Michael L. Gross Washington University, St. Louis, MO, USA
Karl-Anders Karlsson Gothenburg University, Gothenburg, Sweden
Gennaro Marino University of Naples, Naples, Italy
Robert C. Murphy University of Colorado Health Sciences Center, Aurora, CO, USA
Scott D. Patterson Amgen, Thousand Oaks, CA, USA
Jasna Peter-Katalinic University of Münster, Münster, Germany
Peter Roepstorff University of Southern Denmark, Odense, Denmark
Jan Sjövall Karolinska Institute, Stockholm, Sweden

National Institute of General Medical SciencesAdelson Medical Research Foundation